Investment

down-icon
image
Invest in the world’s largest market with US Stocks

Features

down-icon
support-icon
Pro Tools for Pro Traders
Uncover the powerful trading features

Pro Features

icon
support-icon
Built for Investors
Experience investing with simplified features

Pockets

icon

Fees

Safety

Academy

down-icon

More

down-icon
support-icon
Support

About Us

arrow-icon

Pluang+

|

assetIcon

Novavax Inc (NVAX) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.


Technical Indicators

|

|

|

Overall Summary

Bearish (16)

Neutral (4)

Bullish (7)


Performance

NVAX ROI

arrow
+41.05%

% from 52W High

-61.66%
$8.04

52W Low: $3.76

05 Feb 2024

52W High: $20.97

05 Jun 2024


News

Pluang News
Pluang News

Globe Newswire

3mo

2024 Market Research: Vaccines Market Projected to Reach USD 116.63 Billion by 2027 - Rising Disease Prevalence and Prophylactic Applications Fueling Growth



People Also Bought

Pluang
Pluang
BB
BlackBerry Limited
+0.43%

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions



Let’s trade or invest in this asset by signing up or logging in!

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item